1: Can J Ophthalmol. 2010 Aug 1;45(4):352-358 [Epub ahead of print] 

Practical approach to the use of corticosteroids in patients with uveitis.

Cunningham Jr ET, Wender JD.

We review factors contributing to the clinical effectiveness of
various corticosteroid preparations in patients with uveitis and discuss
practical aspects regarding treatment indications, when to administer various
agents, and how best to dose and monitor for both treatment and adverse effects.
Topically administered corticosteroids are typically indicated for the treatment
of anterior uveitis, whereas periocular or intravitreal agents are employed most
often in the management of intermediate or posterior intraocular inflammation.
Patients with vision-threatening uveitis, bilateral inflammation, or uveitis
occurring in the setting of systemic involvement may require oral or intravenous
administration of corticosteroids. Noncorticosteroid immunosuppressive agents
play an important role in limiting the toxic effects of long-term corticosteroid
use.

PMID: 20648092  [PubMed - as supplied by publisher]

2: Can J Ophthalmol. 2010 Aug 1;45(4):342-351 [Epub ahead of print] 

Biology and therapeutic potential of adult retinal stem cells.

Ballios BG, Kooy DV.

Vision loss has a devastating impact on quality of life and activities
of daily living. Pharmacologic treatments serve to stave off disease progression
but do not represent a restorative approach. Cellular transplantation is
considered to be a promising approach for future therapy for retinal
degeneration. There are, however, significant barriers that must be overcome if
cell transplantation is to become a clinical reality. In this review, we focus
on the need for a cellular replacement therapy for retinal disease and the
promise of stem cells as candidate cellular therapeutics. In particular, we
discuss the origins of stem cells in the retina, the discovery and
characterization of retinal stem cells isolated from adult humans, and their
transplantation potential and clinical implications.

PMID: 20648091  [PubMed - as supplied by publisher]

3: Can J Ophthalmol. 2010 Aug 1;45(4):333-341 [Epub ahead of print] 

Current approaches and future prospects for stem cell rescue and regeneration of
the retina and optic nerve.

Dahlmann-Noor A, Vijay S, Jayaram H, Limb A, Khaw PT.

The 3 most common causes of visual impairment and legal blindness in developed
countries (age-related macular degeneration, glaucoma, and diabetic retinopathy)
share 1 end point: the loss of neural cells of the eye. Although recent
treatment advances can slow down the progression of these conditions, many
individuals still suffer irreversible loss of vision. Research is aimed at
developing new treatment strategies to rescue damaged photoreceptors and retinal
ganglion cells (RGC) and to replace lost cells by transplant. The
neuroprotective and regenerative potential of stem and progenitor cells from a
variety of sources has been explored in models of retinal disease and ganglion
cell loss. Continuous intraocular delivery of neurotrophic factors via stem
cells (SC) slows down photoreceptor cells and RGC loss in experimental models.
Following intraocular transplantation, SC are capable of expressing proteins and
of developing a morphology characteristic of photoreceptors or RGC. Recently,
recovery of vision has been achieved for the first time in a rodent model of
retinal dystrophy, using embryonic SC differentiated into photoreceptors prior
to transplant. This indicates that clinically significant synapse formation and
acquisition of the functional properties of retinal neurons, and restoration of
vision, are distinct future possibilities.

PMID: 20648090  [PubMed - as supplied by publisher]

4: Can J Ophthalmol. 2010 Aug 1;45(4):1-5 [Epub ahead of print] 

Predictive factors for the development of visual loss in patients with pituary
macroadenomas and for visual recovery after optic pathway compression.

Monteiro ML, Zambon BK, Cunha LP.

Objective: To investigate clinical and MRI findings that are predictive of both
visual loss in patients with pituitary adenomas and visual recovery after
treatment.Design: Cohort study.Participants: Thirty patients (60 eyes) with
pituitary adenoma.Methods: Patients underwent neuro-ophthalmic examination and
MRI before and after optic chiasm decompression. Visual field (VF) was assessed
using the mean deviation in standard automated perimetry (SAP) and temporal mean
defect, the average of 22 temporal values of the total deviation plot. Tumour
size was measured on sagittal and coronal cuts.Results: Visual loss was found in
47 eyes; 35 had optic atrophy (subtle in 9, moderate in 14, and severe in 12).
Before treatment, the average SAP mean deviation and temporal mean defect were
-11.78 (SD 8.56) dB and -18.66 (SD 11.20) dB, respectively. The chiasm was 17.3
(SD 6.2, range 10-34) mm above the reference line on the sagittal and 21.8 (SD
8.3, range 12-39) mm on the coronal images. Tumour size correlated with the
severity of VF defect. VF improvement occurred in 80% of eyes after treatment.
The degree of optic atrophy, visual loss, and tumour size were significantly
associated with improvement after treatment.Conclusions: The best predictive
factor for visual loss was tumour size, and factors related to visual recovery
were the degree of optic atrophy, the severity of VF defect, and the tumour
size. Diagnosing pituitary adenomas before optic atrophy becomes severe may be
related to a better prognosis in such patients.

PMID: 20648089  [PubMed - as supplied by publisher]

5: Can J Ophthalmol. 2010 Aug 1;45(4):1-6 [Epub ahead of print] 

Scotoma size reduction as an adaptive strategy in age-related macular
degeneration.

Lee KK, Markowitz SN.

Objective: Retinal areas with reduced sensitivity to light stimuli represent the
true scotoma size in patients with age-related macular degeneration (AMD),
whereas the perceived visual field defect area that covers a specific target of
regard may represent an effective size of the same scotoma. This study was
designed to highlight the conceptual difference between the “true scotoma
size” and its “effective scotoma size” counterpart.Design:
Prospective nonrandomized observational case series.Participants: Ten adults
with documented AMD, low vision, and best-corrected visual acuity of
20/50-20/200 in the better eye.Methods: Effective scotoma size and true scotoma
size were calculated from measurements with the macular grid test performed with
automated perimetry and from microperimetry performed with the Nidek MP-1,
respectively.Results: Ten patients aged 70-92 years (mean 81 years) met the
inclusion criteria. Mean effective scotoma size measured with the macular grid
test was 40.19 (SD 34.88) deg2. Mean true scotoma size measured with
microperimetry was 75.17 (SD 56.08) deg2 (p ≤ 0.003). The log unit change in
scotoma size, defined as scotoma utility score, was −55.91%. The effect
size observed for the scotoma utility score was 0.74.Conclusions: Effective
scotoma size experienced by patients with AMD is significantly smaller than true
scotoma size. This reduction may be explained by adaptive variability in eye
positions during any single fixation stability attempt, which ultimately results
in enhanced visual field perception.

PMID: 20648088  [PubMed - as supplied by publisher]

6: Can J Ophthalmol. 2010 Aug 1;45(4):1-6 [Epub ahead of print] 

Combination therapy in exudative age-related macular degeneration: visual
outcomes following combined treatment with photodynamic therapy and intravitreal
bevacizumab.

Wan MJ, Hooper PL, Sheidow TG.

Objective: To measure visual outcomes following combined treatment with
photodynamic therapy (PDT) and intravitreal bevacizumab for exudative
age-related macular degeneration (AMD).Design: Single-centre, retrospective
cohort analysis.Participants: One hundred and seventy-four eyes in 174 patients,
representing a consecutive series of all patients with at least 6 months'
follow-up after combined treatment with PDT and bevacizumab for exudative
AMD.Methods: Each patient was treated with PDT, followed by intravitreal
injection of bevacizumab approximately 30 minutes later. The patients were then
followed at 8-12-week intervals. The primary outcome of the study was the mean
change in visual acuity (VA) from baseline.Results:One hundred seventy-four eyes
in 174 patients completed at least 6 months' follow-up, with a mean duration of
10 months. The mean number of treatments was 3.0 for bevacizumab and 1.4 for
PDT. After stabilization, the mean treatment-free interval was 193 days, and
52% of the patients did not require postinduction retreatment. Mean VA
improved from baseline at 2, 4, and 6 months of follow-up (p < 0.05). In the
subgroup analysis, treatment-naive patients had more favorable visual outcomes
(p < 0.05).Conclusions: The combination of PDT and intravitreal bevacizumab is
an effective therapy for preserving VA in patients with exudative AMD.

PMID: 20648087  [PubMed - as supplied by publisher]

7: Can J Ophthalmol. 2010 Aug 1;45(4):1-5 [Epub ahead of print] 

Microperimetry findings in patients with birdshot chorioretinopathy.

Giuliari GP, Pujari S, Shaikh M, Marvell D, Foster CS.

Objective: To assess the role of microperimetry-1 (MP1) as an ancillary tool in
patients with birdshot chorioretinopathy (BSCR).Design: Observational
cross-sectional study.Participants: Twenty-three eyes of 23 patients.Methods: A
review of medical records was conducted of patients with BSCR seen at our
institution, from January 2008 to August 2008, on whom MP1 had been performed.
Of the 23 eyes included in the study, 15 eyes were identified as having HLA-A29
positive BSCR; 8 eyes with no known ocular pathology were used in the analysis
as the control group. The clinical status was assessed by biomicroscopy,
indirect ophthalmoscopy, and fluorescein angiography.Results: When eyes with
active disease were compared with eyes with inactive disease there was a
statistically significant difference (p = 0.001) between them in the number of
points below 16 dB. The difference was also statistically significant (p = 0.04)
when it was adjusted for visual acuity, associated disease, and age. When eyes
of patients with inactive disease were compared with control eyes, there was a
statistically significant difference (p = 0.01) in the number of points below 16
dB, suggesting that not all patients may recover their full retinal
sensitivities. When eyes of patients with active disease were compared with
controls there was a statistically significant difference (p = 0.01) between
them in the number of points below 16 dB after adjusting for age, visual acuity,
and associated disease (macular edema and epiretinal membrane).Conclusions:
Microperimetric quantification of macular sensitivity in patients with BSCR may
provide an ancillary tool to evaluate activity and may help to assess visual
impairment in these patients.

PMID: 20648086  [PubMed - as supplied by publisher]

8: Can J Ophthalmol. 2010 Aug 1;45(4):1-5 [Epub ahead of print] 

Combined horizontal rectus muscle minimally invasive strabismus surgery for
exotropia.

Pellanda N, Mojon DS.

Objective: To evaluate combined horizontal rectus muscle minimally invasive
strabismus surgery (MISS) for exotropia.Design: Case series.Participants:
Fifty-two consecutive exotropic patients operated on by 1 surgeon with MISS
combined unilateral lateral rectus muscle recession and medial rectus muscle
plication.Methods: Alignment, binocular single vision, conjunctival injection
and swelling, and complications during the first 6 postoperative months were
recorded prospectively. Conjunctival swelling and injection on the first
postoperative day were scored retrospectively and compared with historic
controls operated on with combined recession-plication or recession-resection
using a limbal approach.Results: Conjunctival swelling and injection were mainly
mild on the first postoperative day and less pronounced than after surgery with
a limbal approach (comparison of swelling and injection for MISS vs limbal
opening recession-plication p < 0.001 and for MISS vs limbal opening
recession-resection p < 0.001). A conversion to a limbal approach was necessary
in 3/104 (3%, 95% CI 1%-7%) of all muscles. No scleral perforation or other
serious complication was observed, and no patient needed a repeat operation
within 6 months (0/49, 0%, 95% CI 0%-6%).Conclusions: This study demonstrates
that small-incision, minimal dissection combined recession-plication surgery
induces less conjunctival swelling and injection compared with the usual limbal
approach.

PMID: 20648085  [PubMed - as supplied by publisher]

9: Can J Ophthalmol. 2010 Aug 1;45(4):1-5 [Epub ahead of print] 

Outcome of intravitreal bevacizumab for idiopathic choroidal neovascularization
in the Chinese population.

Qi HJ, Li XX, Tao Y.

Objective: To assess the long-term visual and anatomical outcomes and safety of
intravitreal injection of bevacizumab for idiopathic choroidal
neovascularization (ICNV) in Chinese patients.Design: Retrospective
interventional case series.Participants: Seventy-seven eyes of 77 patients with
ICNV.Methods: Patients were given intravitreal injection of bevacizumab (1.25
mg/0.05 mL) for ICNV between March 2006 and May 2008. Main outcome measures were
changes in best-corrected visual acuity (BCVA), central foveal thickness, which
was measured by optical coherence tomography, and fluorescein angiography
findings.Results: Mean follow-up was 14.3 (SD 2.4, range 10~20) months. Mean
BCVA improved from 0.66 (SD 0.36) logMAR at baseline to 0.25 (SD 0.28) logMAR at
final follow-up (p < 0.001). Sixty-one patients (79%) gained BCVA of >=2 Snellen
lines, and 1 eye (1%) lost BCVA of >=2 Snellen lines. Mean central foveal
thickness decreased from 365 (SD 124) microm at baseline to 211 (SD 94) microm
at final visit (p < 0.001). Sixty-two eyes (81%) needed reinjection. Both BCVA
improvement and the change in central foveal thickness between the 1- time
injection group and the multi-injections group were not statistically
significant (p = 0.45 and p = 0.19, respectively). No significant ocular or
systemic adverse effects were observed.Conclusions: The long-term results
suggest an encouraging efficacy and safety of intravitreal bevacizumab for ICNV
in Chinese patients.

PMID: 20648084  [PubMed - as supplied by publisher]

10: Can J Ophthalmol. 2010 Aug 1;45(4):1-4 [Epub ahead of print] 

The short adjustable suture.

Budning AS, Day C, Nguyen A.

Objective: To describe a new, adjustable suture technique for strabismus surgery
that is safe and effective and allows for adjustment during the postoperative
week only when required.Design: Retrospective review.Participants: A total of
304 patients, of which 149 were male and 155 female, with an age range from 4 to
89 years and a median age of 42 years.Methods: All patients treated with the
short adjustable suture technique between September 2007 and April 2009 were
reviewed retrospectively. Details of cause, complexity and reoperation,
operative success, requirement for adjustment, and success of adjustment were
collected. Success was defined as horizontal deviation ≤ 10 prism diopters
(PD) and vertical deviation ≤ 6 PD.Results: Overall, 84% of horizontal
deviations and 74% of vertical deviations were treated successfully with 1
operation. Twenty-one adjustments were performed. Complications included 1
slipped slip knot and 6 conjunctival or Tenon cysts.Conclusions: The short
adjustable suture is a safe and effective variation of the standard slip-knot
adjustable suture technique. It allows for adjustment up to 6 days
postoperatively with minimal patient discomfort. When adjustment is not
indicated, the suture can be left in place to absorb.

PMID: 20648083  [PubMed - as supplied by publisher]

11: Can J Ophthalmol. 2010 Aug 1;45(4):1-7 [Epub ahead of print] 

Testing toxicity of multiple intravitreal injections of bevacizumab in rabbit
eyes.

Xu W, Wang H, Wang F, Jiang Y, Zhang X, Wang W, Qian J, Xu X, Sun X.

Objective: To evaluate the potential toxicity of repeated intravitreal
injections of bevacizumab in rabbit eyes.Design: Randomized, placebo-controlled
experimental animal study.Participants: Fourteen chinchilla rabbits; 12 assigned
to the experimental group and 2 assigned to the normal control group.Methods:
Three sequential, biweekly, intravitreal injections of bevacizumab in doses of
2.5 mg/0.1 mL or 5.0 mg/0.2 mL were performed on each rabbit. Evaluations
included intraocular pressure (IOP), aqueous flare, B-scan ultrasound, fundus
photography, ultrasound biomicroscopy, electroretinography (ERG), and visually
evoked potentials (VEPs) performed at baseline and during the follow-up period.
The eyes were enucleated at 1 week and 4 weeks after the last intravitreal
injection, and underwent light and electron microscopic evaluations, as well as
testing for apoptotic activity.Results: After intravitreal injections, no
changes were found by regular clinical observation and IOP tests. There was no
significant difference in the anterior chamber inflammatory activity evaluated
by the laser flare meter. No evidence of retinal toxicity was seen after
intravitreal bevacizumab at doses of 2.5 and 5.0 mg by either ERG or flash VEPs.
Electron microscopy did show the presence of inflammatory cells and some
ultrastructural changes in the photoreceptor cells in the 5.0 mg experimental
group 1 week after the third injection. Mild to moderate apoptosis of
photoreceptors was detected in the 5.0 mg group at the same time.Conclusions:
The biweekly, multiple intravitreal injections of bevacizumab did not result in
evidence of toxicity in regular clinical and functional observations at both 2.5
mg and 5.0 mg doses. The 5.0 mg dose may induce transient inflammation,
ultrastructural abnormalities, and apoptosis.

PMID: 20648082  [PubMed - as supplied by publisher]

12: Can J Ophthalmol. 2010 Aug 1;45(4):1-7 [Epub ahead of print] 

Comparing a traditional single optotype visual acuity test with a computer-based
visual acuity test for childhood amblyopia vision screening: a pilot study.

Schlenker MB, Christakis TJ, Braga-Mele RM.

Objective: To investigate the effectiveness of a traditional flip-chart optotype
test, the Sheridan Gardiner test (SGT), in measuring visual acuity and detecting
amblyopia, compared with a free, computer-based test (CBT),
LazyeyeTest.org.Design: Prospective, masked, cross-over study.Participants:
Seventy kindergarten-aged children from a downtown Toronto elementary school
enrolled in the Kids2See vision screening program.Methods: Visual acuity in the
children was measured monocularly using both tests. The visual acuity results,
number of referrals, and outcomes of referrals were compared, as was the
usability from the perspective of the child and the vision screener.Results: The
children were more likely to score low visual acuity values with the CBT, a
result predicted by the existence of crowding bars on the CBT's optotypes. The
CBT referred an extra 5 children than the SGT, and of the 4 who saw an
ophthalmologist 2 had amblyopia. The SGT referred one child not referred by the
CBT. The Cohen's kappa coefficient was 0.67 and the difference in referral rates
was not significant (p = 0.13). Relative to the SGT, the sensitivity of the CBT
was 88%, specificity was 92%, positive predictive value was 58%, and negative
predictive value was 98%. The CBT appeared to be easier and more efficient to
administer, more stimulating, and was preferred by the children.Conclusions:
Replacing the SGT with LazyeyeTest.org would increase the efficiency and likely
the sensitivity of amblyopia screening. Further research is warranted to confirm
the outcomes and to determine if the CBT can be administered accurately by lay
screeners.

PMID: 20648081  [PubMed - as supplied by publisher]

13: Can J Ophthalmol. 2010 Aug 1;45(4):1-2 [Epub ahead of print] 

Use of intraocular ketorolac tromethamine for the treatment of chronic cystoid
macular edema.

Margalit E, Boysen JL, Zastrocky JP, Katz A.

PMID: 20648080  [PubMed - as supplied by publisher]

14: Can J Ophthalmol. 2010 Aug 1;45(4):1-2 [Epub ahead of print] 

Spontaneous resolution of foveal cysts associated with X-linked retinoschisis as
observed by optical coherence tomography.

Jo YJ, Kim KN, Kim JY.

PMID: 20648079  [PubMed - as supplied by publisher]

15: Can J Ophthalmol. 2010 Aug 1;45(4):1 [Epub ahead of print] 

Cyclops.

[No authors listed]

PMID: 20648078  [PubMed - as supplied by publisher]

16: Can J Ophthalmol. 2010 Aug 1;45(4):1 [Epub ahead of print] 

F.Y.Eye.

[No authors listed]

PMID: 20648077  [PubMed - as supplied by publisher]

17: Can J Ophthalmol. 2010 Aug 1;45(4):1 [Epub ahead of print] 

Corrigendum: Silicone oil-induced bilateral granulomatous uveitis.

Mandelcorn MS.

PMID: 20648076  [PubMed - as supplied by publisher]

18: Can J Ophthalmol. 2010 Oct 1;45(5):1-7 [Epub ahead of print] 

Relation between blue-on-yellow perimetry and optical coherence tomography in
normal tension glaucoma.

Zhong Y, Zhou X, Cheng Y, Xie L.

Objective: To assess the relation between blue-on-yellow perimetry (B/YP)
indices and optical coherence tomography (OCT) parameters in normal tension
glaucoma (NTG) patients and to investigate the diagnostic ability of B/YP and
OCT in discriminating NTG from normal eyes.Design: Cross-sectional
study.Participants: Eighty normal subjects (80 eyes) and 80 NTG patients (80
eyes) were enrolled in the study.Methods: All patients underwent white-on-white
perimetry, B/YP, and OCT measurement. The correlation between B/YP indices and
OCT parameters was analyzed. The area of the receiver operating characteristic
(ROC) curve was calculated to discriminate NTG patients from normal
subjects.Results: A highly significant correlation was found between B/YP mean
deviation (MD) and average thickness of the retinal nerve fibre layer (r2 =
0.707, p = 0.000), and a moderately significant correlation was found between
B/YP MD and temporal average (r2 = 0.437, p = 0.010) in the early NTG patients.
A mildly or moderately significant correlation was found between B/YP MD and
average thickness, inferior average, temporal average, superior maximum, and
maximum-minimum (r2 = 0.212-0.498, p = 0.001-0.048) in the moderate or late NTG
patients. The area under the ROC curve at the B/YP MD was 0.896, and the 3 OCT
parameters with the widest area under the curve were average thickness (0.957),
inferior average (0.932), and superior average (0.913). Average thickness showed
the highest sensitivity (93%) with specificities at 90% and 80%.Conclusions: The
significant correlation between B/YP indices and OCT parameters in NTG patients
suggests that the 2 tests detect similar areas or amounts of NTG damage and
could be used for NTG early diagnosis.

PMID: 20648075  [PubMed - as supplied by publisher]

19: Can J Ophthalmol. 2010 Oct 1;45(5):1-8 [Epub ahead of print] 

Selective and pan-blockade agents in the anti-angiogenic treatment of
proliferative diabetic retinopathy: a literature summary.

Giuliari GP, Guel DA, Cortez MA, Cortez RT.

Diabetes mellitus is a major health concern in the modern world. Several
sight-threatening ocular conditions are included in the array of health problems
associated with this disease. Understandably, 2 of the more sight-threatening
problems, proliferative diabetic retinopathy (PDR) and diabetic macular edema
(DME), have received a great deal of attention in recent years. Pivotal studies,
such as the Early Treatment Diabetic Retinopathy Study and the Diabetic
Retinopathy Study, have established laser photocoagulation as the accepted
treatment modality. The last decade has seen a surge in clinical data supporting
the use of pharmacologic therapy in place of the often damaging laser therapy.
Supporting data are based on the establishment of vascular endothelial growth
factor (VEGF) as a key facilitator of disease progression in diabetic
retinopathy. We will discuss the advantages and disadvantages of both selective
and pan-blockade anti-VEGF agents available today in an effort to help guide
physicians wishing to use these agents to treat PDR and DME.

PMID: 20648074  [PubMed - as supplied by publisher]

20: Can J Ophthalmol. 2010 Oct 1;45(5):1-5 [Epub ahead of print] 

Evaluation of focal retinal function using multifocal electroretinography in
patients with X-linked retinoschisisy.

Sen P, Roy R, Maru S, Ravi P.

Objective: To evaluate focal retinal function in patients presenting with
features of X-linked retinoschisis (XLRS), with the use of multifocal
electroretinography (mfERG).Design: Consecutive observational case-control
study.Participants: Eighteen eyes of 9 patients who presented to the retina
clinic of Sankara Nethralaya from 2005 to 2008.Methods: XLRS was diagnosed
clinically and corroborated with full-field electroretinogram (ffERG), mfERG,
and optical coherence tomography. ffERG and mfERG recordings were done with
VERIS 5.2.2X according to International Society for Clinical Electrophysiology
of Vision standards. The mfERG stimulus consisted of 103 hexagons flickered at a
75 Hz frame rate, subtended 35 degrees horizontally and 31 degrees vertically at
a viewing distance of 53 cm. The amplitudes and implicit times of ffERG and
first-order kernels of mfERG were analyzed and compared with those of the
controls.Results: P1 and N1 amplitudes were reduced and P1 and N1 implicit times
were prolonged significantly in patients with XLRS, compared with
controls.Conclusions: mfERG helps estimate focal retinal function in patients
with XLRS.

PMID: 20648073  [PubMed - as supplied by publisher]

21: Can J Ophthalmol. 2010 Oct 1;45(5):1-2 [Epub ahead of print] 

Chemoreduction for nonvisualized retinoblastoma hidden behind dense cataract.

Nallasamy S, Ramasubramanian A, Shields CL, Tipperman R, Shields JA.

PMID: 20648072  [PubMed - as supplied by publisher]

22: Can J Ophthalmol. 2010 Oct 1;45(5):1-2 [Epub ahead of print] 

Purtscher-like retinopathy after retrobulbar anaesthesia in a patient with an
intracanal mass.

Cho HK, Jee D, Lee WK, Shin CH, Ryu JW.

PMID: 20648071  [PubMed - as supplied by publisher]

23: Can J Ophthalmol. 2010 Oct 1;45(5):1 [Epub ahead of print] 

Public Health adds value to an investigation of epidemic keratoconjunctivitis.

Mema SC, Macdonald J, Wyse JP, Gonder T, Musto R, McIntyre L.

PMID: 20648070  [PubMed - as supplied by publisher]

24: Can J Ophthalmol. 2010 Oct 1;45(5):1-2 [Epub ahead of print] 

Disc drusen complicated by optic disc hemorrhage in childhood.

Neffendorf JE, Mulholland C, Quinlan M, Lyons CJ.

PMID: 20648069  [PubMed - as supplied by publisher]

25: Can J Ophthalmol. 2010 Oct 1;45(5):1-2 [Epub ahead of print] 

Atypical macular coloboma in a patient with adult vitelliform dystrophy.

Panagiotidis D, Karagiannis D, Theodossiadis P, Tsoumpris I, Vergados I.

PMID: 20648068  [PubMed - as supplied by publisher]

26: Can J Ophthalmol. 2010 Dec 1;45(6):1-2 [Epub ahead of print] 

Progressive changes from idiopathic macular telangiectasia seen with spectral
domain optical coherence tomography.

Fallano KA, Ibrahim M, Nguyen QD, Do DV.

PMID: 20648067  [PubMed - as supplied by publisher]

27: Can J Ophthalmol. 2010 Dec 1;45(6):1-2 [Epub ahead of print] 

Intraocular metastatic Wilms' tumour in a child.

Al-Mesfer S, Alkatan H.

PMID: 20648066  [PubMed - as supplied by publisher]

28: Can J Ophthalmol. 2010 Dec 1;45(6):1-2 [Epub ahead of print] 

Diagnosis and management of a spontaneous hyphema from a microhemangioma
suspended in the anterior chamber: a case report.

Wyse JP, McWhae J, Simms C.

PMID: 20648065  [PubMed - as supplied by publisher]

29: Can J Ophthalmol. 2010 Jun;45(3):293-4. 

Pupil block following inadvertent back to front implantation of a 5 degrees
vaulted posterior chamber intraocular lens.

Li Yim JF, Ross JZ, Jay JL.

PMID: 20628424  [PubMed - in process]

30: Can J Ophthalmol. 2010 Jun;45(3):290-3. 

Tsukamurella: an emerging opportunistic ocular pathogen.

Almeida DR, Miller D, Alfonso EC.

PMID: 20628423  [PubMed - in process]